Neuropathologic Features Associated with Basal Forebrain Atrophy in Alzheimer Disease
Affiliations
Objective: To study the neuropathologic correlates of cholinergic basal forebrain (BF) atrophy as determined using antemortem MRI in the Alzheimer disease (AD) spectrum.
Methods: We determined associations between BF volume from antemortem MRI brain scans and postmortem assessment of neuropathologic features, including neuritic plaques, neurofibrillary tangles (NFTs), Lewy body (LB) pathology, and TDP-43, in 64 cases of the Alzheimer's Disease Neuroimaging Initiative cohort. For comparison, we assessed neuropathologic features associated with hippocampal and parahippocampal gyrus atrophy. In addition to region of interest-based analysis, we determined the association of neuropathologic features with whole brain gray matter volume using regionally unbiased voxel-based volumetry.
Results: BF atrophy was associated with Thal amyloid phases (95% confidence interval [CI] -0.49 to -0.01, = 0.049) and presence of LB pathology (95% CI -0.54 to -0.06, = 0.015), as well as with the degree of LB pathology within the nucleus basalis Meynert (95% CI -0.54 to -0.07, = 0.025). These effects were no longer significant after false discovery rate (FDR) correction. Hippocampal atrophy was significantly associated with the presence of TDP-43 pathology (95% CI -0.61 to -0.17, = 0.003; surviving FDR correction), in addition to dentate gyrus NFT load (95% CI -0.49 to -0.01, = 0.044; uncorrected). Voxel-based analysis confirmed spatially restricted effects of Thal phases and presence of LB pathology on BF volume.
Conclusions: These findings indicate that neuropathologic correlates of regional atrophy differ substantially between different brain regions that are typically involved in AD-related neurodegeneration, including different susceptibilities to common comorbid pathologies.
Wisse L, Wuestefeld A, Murray M, Jagust W, La Joie R Alzheimers Dement. 2025; 21(2):e14582.
PMID: 39985478 PMC: 11846482. DOI: 10.1002/alz.14582.
Schumacher J, Teipel S, Storch A Alzheimers Res Ther. 2025; 17(1):28.
PMID: 39865328 PMC: 11771035. DOI: 10.1186/s13195-025-01678-x.
Ortega-Cruz D, Rabano A, Strange B Alzheimers Res Ther. 2025; 17(1):16.
PMID: 39789603 PMC: 11714914. DOI: 10.1186/s13195-024-01633-2.
White matter hyperintensities and cholinergic degeneration as Lewy body disease.
Kang S, Jeon S, Kim Y, Jeon S, Choi M, Lee Y Ann Clin Transl Neurol. 2024; 12(1):97-109.
PMID: 39654300 PMC: 11752093. DOI: 10.1002/acn3.52257.
Disruption in functional networks mediated tau spreading in Alzheimer's disease.
Nabizadeh F Brain Commun. 2024; 6(4):fcae198.
PMID: 38978728 PMC: 11227975. DOI: 10.1093/braincomms/fcae198.